Skip to main content
. 2015 Jul 8;7(13):1797–1806. doi: 10.4254/wjh.v7.i13.1797

Table 3.

Summary of studies included in the pooled analyses of transjugular intrahepatic portosystemic shunt in patients with refractory hepatic hydrothorax

Ref. No. of patients Complete response (%) Partial response (%) 45-d mortality (%) 1-yr survival (%) Predictors of mortality
Gordon et al[14] 24 58 21 21 NA TIPSS nonresponse
CTP class C
Jeffries et al[24] 12 42 17 25 NA Age > 65 yr
Siegerstetter et al[26] 40 53 28 13 64 Age > 60 yr
Spencer et al[27] 21 57 10 29 NA Medical comorbidities
Wilputte et al[28] 28 57 11 14 41 CTP score > 10
Mayo score > 1.5
Dhanasekaran 73 59 21 19 48 MELD > 15
et al[23] Nonresponse
Elevated creatinine

CTP: Child-Turcotte-Pugh; MELD: Model for end-stage liver disease; NA: Not applicable; TIPSS: Transjugular intrahepatic portosystemic stent shunt.